Results 171 to 180 of about 9,057,173 (269)

Characterization of a Missense Mutation in the Catalytic Domain and a Splicing Mutation of Coagulation Factor X Compound Heterozygous in a Chinese Pedigree. [PDF]

Genes (Basel), 2021
Feng Y, Ma J, Tang LV, Lin W, Tao Y, Cheng Z, Hu Y.   +6 more
europepmc   +1 more source

SensRORing cholesterol to drive protumoral myelopoiesis

Molecular Oncology, EarlyView.
Bleve et al. uncover a cholesterol‐driven immune evasion pathway, where RORγ‐dependent myelopoiesis shapes tumor immunosuppression. Targeting RORγ and PCSK9 emerges as a strategy to boost cancer immunotherapy. Protumoral myelopoiesis is a determinant of immunoevasion and tumor spread in many malignancies.
Sara Gennari, Luigi Nezi, Teresa Manzo
wiley   +1 more source

NMR-identification of the interaction between BRCA1 and the intrinsically disordered monomer of the Myc-associated factor X. [PDF]

Protein Sci
Epasto LM, Pötzl C, Peterlik H, Khalil M, Saint-Pierre C, Gasparutto D, Sicoli G, Kurzbach D.   +7 more
europepmc   +1 more source

[Congenital factor X deficiency: a retrospective analysis of 11 cases]. [PDF]

Zhonghua Xue Ye Xue Za Zhi, 2022
Li RW, Liu XF, Xue F, Chen YF, Liu W, Fu RF, Zhang L, Yang RC.   +7 more
europepmc   +1 more source

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

Molecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte   +7 more
wiley   +1 more source

Hereditary factor X deficiency in America survey: impact on quality of life and burden of disease in patients and caregivers. [PDF]

Blood Coagul Fibrinolysis
Branchford B, Clark K, Stanford RH, Garner DA, Huang SP, Wolford E.   +5 more
europepmc   +1 more source

Biological Properties of the Naturally Occurring Plasma Inhibitor to Activated Factor X

, 1971
E.T. Yin, Stanford Wessler, Pamela J. Stoll   +2 more
openalex   +1 more source

Long non‐coding RNAs as therapeutic targets in head and neck squamous cell carcinoma and clinical application

FEBS Open Bio, EarlyView.
Long non‐coding RNAs (lncRNAs) occupy an abundant fraction of the eukaryotic transcriptome and an emerging area in cancer research. Regulation by lncRNAs is based on their subcellular localization in HNSCC. This cartoon shows the various functions of lncRNAs in HNSCC discussed in this review.
Ellen T. Tran, Ruchi A. Patel, Amogh Chariyamane, Ratna B. Ray   +3 more
wiley   +1 more source

Successful Treatment of Factor X Deficiency in a Patient with Lymphoplasmacytic Lymphoma with Bendamustine Plus Rituximab Regimen: A Case Report and Literature Review. [PDF]

J Blood Med, 2021
Rungjirajittranon T, Chinthammitr Y, Hantaweepant C.   +2 more
europepmc   +1 more source

Human hepatoma cells secrete single chain factor X, prothrombin, and antithrombin III [PDF]

, 1984
DS Fair, BR Bahnak
openalex   +1 more source